Immunosuppressants and Immunomodulators Flashcards
immunosuppressant definition
- drugs that increase risk of infection
immunosuppressants target - broad/narrow
- broad targets/effects
age of immunosuppressant drugs
- old drugs
immunomodulators definition
- drugs that DO NOT increase risk of infection
Immunomodulators target - broad/narrow
- narrow targets/effects
age of immunomodulator drug
- new drugs
four characteristics of an inflammatory immune response
- pain (dolor)
- heat (calor)
- erythema (rumor)
- swelling (tumor)
eicanosanoids synthesized by
- most cells
eicanosanoids role in inflammation
- act as local vasodilators
what molecules do drugs affect in eicosanoid production/activity?
- prostaglandins
- leukotrienes
what molecules do drugs affect in inflammatory cytokine production/activity
- TNFa
- IL-2
- IL-5
- IL-6
what molecules do drugs affect in leukocyte activation/proliferation?
- Th-cells
- B-cells
- eosinophils
- mast cells
what are eicosanoids derived from?
plasma membrane lipids
what creates arachidonic acid
- from plasma membrane lipids
- by phospholipase A2
what are the three eicosanoids derived from arachidonic acid?
- prostaglandin E2
- Thromboxane A2
- Leukotriene E4
prostaglandins E2 produced by
- most cells
thromboxane A2 produced by
- platelets
leukotriene E4 produced by
- leukocytes
cyclooxygenase inhibitors inhibit what process
- synthesis of prostanoids
big class of COX inhibitors
- NSAIDs
COX1 constitutive/inducible
- constitutive
COX1 responsible for
- homeostatic functions
COX2 constitutive/inducible
- inducible
COX2 responsible for
- inflammatory response
homeostatic effects of prostaglandins
- renal homeostasis
- gastric mucosal production
- platelet function
inflammatory effects of prostaglandins
- pain
- inflammation
- fever
- limited homeostatic effects
toxic effects of prostaglandin inhibitors target
- renal homeostasis
- gastric mucosal production
- platelet function
therapeutic effects of prostaglandin inhibitors target
- pain
- inflammation
- fever
- limited homeostatic effects
- platelet function
selectivity of NSAIDS for COX
- vary in their selectivity
more toxicities associated with which COX inhibitors
- COX1
- due to inhibition of homeostatic function
fewer toxicities associated with which COX inhibitors
- COX2
- but not no toxicities
- due to inhibition of inflammatory effects
prostaglandin E2 (PGE2) role
- responsible for producing and maintaining gastric mucosal protection lining the inside of the stomach
prostaglandin E2 target toxicities of NSAID use
- long term use can lead to deterioration of mucous layer
- can lead to gastric bleeding or ulcers
thromboxane A2 (TXA2) role
- promotes platelet activation for clotting
thromboxane A2 toxicities of NSAID use
- long term use will increase risk of bleeding disorders
thrombaxane A2 target therapeutic of NSAID use
- inhibition of clotting may be therapeutic when treating patients to prevent MI or thrombotic/embolic stroke
aspirin MOA
- irreversibly inhibits COX1/2 through covalent modification
- of acetyl group
aspirin irreversible activation of COX-1 effect
- leads to inhibition of TXA2
- avoiding vasoconstriction and platelet aggregation induced by this prostanoid
aspirin acetylation of COX-2 effect
- inhibition of prostaglandin production
- production of eicosatetraenoic acid as a substrate for new biologically active mediators aspirin triggered lipotoxins
aspirin approved uses
- pain
- inflammation - RA, OA
- fever - rheumatic fever
- ischemic conditions
Off label uses of aspirin
- Kawasaki disease
- prevention of pre-eclampsia
- prevention of colorectal cancer
symptoms of Kawasaki disease
- conjunctivitis
- swollen lymph nodes
- swollen hands and feet
- changes in oral mucosa
- rash
diagnosis Kawasaki
- 4 out of 5 criteria
- + high fever